About IVDS
In Vitro Diagnostic Solutions (IVDS)
IVDS was founded to offer point-of-care, simple-to-use diagnostics for rare metabolic diseases. We are composed of skilled engineers and scientists for innovative technology development. Our current products include the IVDS Onsight platform, urine test strips, and more products in development.
Who We Serve
Rare diseases, shared needs
Rare metabolic and related conditions touch clinicians, families, and health systems in different ways but all depend on timely, reliable data. The Onsight ecosystem is designed to serve each stakeholder.
Clinicians, clinics, and hospitals
Metabolic specialists, pediatricians, nurses, and dietitians can use Onsight-generated results to:
- See analyte levels in minutes instead of waiting on external lab reports
- Adjust diet, medications, and monitoring schedules based on current data
- Integrate point-of-care and home testing into existing clinic and telehealth workflows
For institutions, the platform offers a path to extend rare disease expertise beyond the walls of the clinic and into patients’ homes.
Patients and families
For individuals living with PKU, G6PD deficiency, ADA2 deficiency, fatty acid oxidation disorders, and other conditions and for the caregivers who support them, the Onsight ecosystem aims to:
- Provide clearer, more frequent feedback via small-sample tests
- Reduce the burden of repeated hospital visits and mailed samples
- Make complex lab values easier to understand through app-based visualization and education
Our development is informed by ongoing studies and close collaboration with patient communities and foundations in rare disease.
Partners
We collaborate with:
- Hospitals and labs interested in deploying point-of-care and at-home tests for rare diseases
- Pharmaceutical and biotech companies seeking companion diagnostics or longitudinal monitoring tools in trials
- NGOs and global health organizations working in malaria- and anemia-endemic regions where G6PD and hemoglobin testing are critical
- Research groups and foundations exploring new biomarkers and use cases for Onsight-enabled assays
Partners gain access to a flexible platform, assay development expertise, and a growing evidence base across multiple analytes.